Clinical effectiveness of tolvaptan in patients with acute decompensated heart failure and renal failure: design and rationale of the AQUAMARINE study.
about
Dual Impact of Tolvaptan on Intracellular and Extracellular Water in Chronic Kidney Disease Patients with Fluid Retention.Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunctionPrognostic importance of sodium level trajectory in acute heart failure.Heart failure epidemiology and novel treatments in Japan: facts and numbers.
P2860
Clinical effectiveness of tolvaptan in patients with acute decompensated heart failure and renal failure: design and rationale of the AQUAMARINE study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Clinical effectiveness of tolv ...... onale of the AQUAMARINE study.
@en
Clinical effectiveness of tolv ...... onale of the AQUAMARINE study.
@nl
type
label
Clinical effectiveness of tolv ...... onale of the AQUAMARINE study.
@en
Clinical effectiveness of tolv ...... onale of the AQUAMARINE study.
@nl
prefLabel
Clinical effectiveness of tolv ...... onale of the AQUAMARINE study.
@en
Clinical effectiveness of tolv ...... onale of the AQUAMARINE study.
@nl
P2093
P2860
P1476
Clinical effectiveness of tolv ...... ionale of the AQUAMARINE study
@en
P2093
Atsushi Takahashi
Harumizu Sakurada
Hiroyuki Fujii
Kaoru Okishige
Kaoru Sugi
Makoto Noda
Makoto Suzuki
Satoshi Yamaguchi
Tamotsu Tejima
P2860
P356
10.1007/S10557-013-6491-8
P577
2014-02-01T00:00:00Z